Status:
UNKNOWN
Comprehensive DNA Methylation Profiling in Crohn's Disease
Lead Sponsor:
Jinling Hospital, China
Conditions:
Crohn Disease
Methylation
Eligibility:
MALE
18-60 years
Brief Summary
Previous studies have indicated that abnormal DNA methylation frequently occurs in the mucosa in Crohn's disease. Comprehensive DNA methylation profiling of the inflamed and non-inflamed ileal mucosa ...
Eligibility Criteria
Inclusion
- Active Crohn's disease(CDAI score≥ 150)
Exclusion
- No ileal lesions
- Under treatment of immunomodulators, biologic agents or steroids
Key Trial Info
Start Date :
January 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 30 2017
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT03272152
Start Date
January 1 2017
End Date
September 30 2017
Last Update
September 5 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jinling Hospital
Nanjing, Jiangsu, China, 210002